News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Oxford Biotherapeutics Relocates Its UK Base to the Oxford Science Park, Aiming to Accelerate the Development of Immuno-oncology and ADC-based Cancer Treatments
Thursday, October 12, 2023Oxford BioTherapeutics Ltd OBT a clinicalstage oncology company specializing in immunooncology and antibodydrug conjugate ADCbased therapies has relocated its UK headquarters to The Schrodinger Building within The Oxford Science Park
Salipro Biotech and Icosagen Announce a Collaboration for Antibody Discovery
Wednesday, October 11, 2023Salipro Biotech AB a Swedish biotech company and Icosagen an Estonian biotechnology company have recently announced their collaboration in a multitarget antibody research agreement aimed at advancing drug discovery programs focused on challenging mem...
Scorpion Therapeutics and Pierre Fabre Laboratories Initiate Phase 1/2 Clinical Trial
Wednesday, October 11, 2023Scorpion Therapeutics Inc and Pierre Fabre Laboratories have jointly announced the commencement of a Phase clinical trial for STX a groundbreaking tyrosine kinase inhibitor tailored to target epidermal growth factor receptor EGFR and ERBB HER Exon...
Valo Therapeutics Acquires Bruker Corporation's Latest Mass Spectrometer Platform for Tumor Antigen Identification Through Valotx's Peptichip Technology
Wednesday, October 11, 2023Valo Therapeutics Oy ValoTx has made a significant announcement as the first European biotech company to incorporate the Bruker Corporations cuttingedge timsTOF Ultra mass spectrometer and liquid chromatography platform into its operations
RAD Granted Approval for Phase 1 Clinical Trial of PDL1-Nanobody in Non-Small Cell Lung Cancer
Tuesday, October 10, 2023Radiopharm Theranostics ASXRAD has obtained approval from the Human Research Ethics Committee HREC to initiate its Phase I study in Australia marking the first human trials for the companys therapy designed to treat patients with PDLpositive nonsmall...
FDA Grants Orphan Drug Designation to Ultimovacs' UV1 Vaccine for Mesothelioma Treatment
Monday, October 09, 2023Ultimovacs ASA OSE ULTI a prominent biotechnology company specializing in innovative cancer vaccines has secured Orphan Drug Designation ODD from the US Food and Drug Administration FDA for their therapeutic cancer vaccine UV intended for the treatme...
FDA Approves Arcutis' ZORYVE® (Roflumilast) Cream 0.3% for Psoriasis Treatment in Children Ages 6 to 11
Saturday, October 07, 2023Arcutis Biotherapeutics Inc NASDAQ ARQT is an early commercialstage biopharmaceutical company with a focus on advancing innovations in immunodermatology
Abbvie Exercises Exclusive Option to Acquire Mitokinin, Enhancing Its Neuroscience Pipeline
Friday, October 06, 2023AbbVie NYSE ABBV has officially acquired Mitokinin a biotech firm in the discovery phase which has been working on a pioneering treatment for Parkinsons Disease PD
BIOVECTRA and Acuitas Therapeutics Enter Into Partnership for Unique Lipid Nanoparticle (LNP) Delivery System in the Production of MRNA-based Therapies
Friday, October 06, 2023BIOVECTRA and Acuitas Therapeutics Inc have announced a collaborative technology transfer service agreement BIOVECTRA will gain access to Acuitas advanced Lipid Nanoparticle LNP technology platform for manufacturing mRNAbased therapeutics on a nonexc...
Ankyra Therapeutics Enters Clinical Trial Collaboration and Supply Deal with Merck to Assess ANK-101 Alongside KEYTRUDA® in Advanced Solid Tumor Patients
Thursday, October 05, 2023Ankyra Therapeutics a clinical biotechnology company specializing in the development of a unique form of localized immunotherapy known as anchored immunotherapy has announced a collaboration and supply agreement for a clinical trial with Merck known...
